Literature DB >> 27547141

Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.

Robert W Godley, Eduardo Hernandez-Vila.   

Abstract

Entities:  

Keywords:  Anti-inflammatory agents, non-steroidal; aspirin/history/therapeutic use; history, 19th century; history, 20th century; myocardial infarction/prevention & control; platelet aggregation inhibitors; prevention, primary; prevention, secondary; stroke/prevention & control; vascular disease

Mesh：

Substances：

Year:  2016        PMID： 27547141      PMCID： PMC4979389          DOI： 10.14503/THIJ-16-5807

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  8 in total

Review 1.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

2.  Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.

Authors: 
Journal:  Contemp Clin Trials       Date:  2013-10-07       Impact factor: 2.226

3.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

4.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

5.  Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-03-17       Impact factor: 25.391

6.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

Review 7.  The discovery of aspirin's antithrombotic effects.

Authors:  Jonathan Miner; Adam Hoffhines
Journal:  Tex Heart Inst J       Date:  2007

8.  Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.

Authors:  Giorgia De Berardis; Michele Sacco; Virgilio Evangelista; Alessandro Filippi; Carlo B Giorda; Gianni Tognoni; Umberto Valentini; Antonio Nicolucci
Journal:  Trials       Date:  2007-08-28       Impact factor: 2.279
  8 in total
  4 in total

1.  Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study.

Authors:  Lan Yang; Pingping Zhao; Jing Zhao; Juan Wang; Lei Shi; Xiaopeng Wang
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

2.  Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study.

Authors:  Blanca Lorman-Carbó; Josep Lluís Clua-Espuny; Eulàlia Muria-Subirats; Juan Ballesta-Ors; Maria Antònia González-Henares; José Fernández-Sáez; Francisco M Martín-Luján
Journal:  BMC Geriatr       Date:  2021-02-05       Impact factor: 3.921

3.  A multicenter case-control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users.

Authors:  Narmeen Mallah; Maruxa Zapata-Cachafeiro; Carmelo Aguirre; Eguzkiñe Ibarra-García; Itziar Palacios-Zabalza; Fernando Macías García; Julio Iglesias García; María Piñeiro-Lamas; Luisa Ibáñez; Xavier Vidal; Lourdes Vendrell; Luis Martin-Arias; María Sáinz Gil; Verónica Velasco-González; Ángel Salgado-Barreira; Adolfo Figueiras
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

4.  Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials.

Authors:  Yaowang Lin; Zhigang Cai; Shaohong Dong; Huadong Liu; Xinli Pang; Qiuling Chen; Jie Yuan; Qingshan Geng
Journal:  Front Pharmacol       Date:  2022-09-30       Impact factor: 5.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.